A fluorescence video-endoscopy technique for defection of gene transfer and expression

Gene Therapy

Volumn 5, Issue 2, 1998, Pages 166-173

  Flotte, T R ^a,c   Beck, S E ^b   Chesnut, K ^a   Potter, M ^a   Poirier, A ^a   Zolotukhin, S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adeno associated virus (AAV); Adenovirus (Ad); Bronchoscopy; Endoscopy; Gene therapy; Green fluorescent protein (GFP)

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; BRUSH BORDER; CONTROLLED STUDY; ENDOSCOPY; EXPRESSION VECTOR; FIBEROSCOPE; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; IMAGING SYSTEM; LIGHT FILTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RABBIT; TECHNIQUE;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; BRONCHUS; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031909281     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300579     Document Type: Article

References (24)

1. Chalfie M et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805.
2. Zolotukhin S et al. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
3. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
4. Rosenfeld MA et al. Increasing expression of the normal human CFTR cDNA in cystic fibrosis epithelial cells results in a progressive increase in the level of CFTR protein expression, but a limit on the level of cAMP-stimulated chloride secretion. Hum Gene Ther 1994; 5: 1121-1129.
5. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis (see comments) (published erratum appears in Nature Med 1995, 1: 272). Nature Med 1995; 1: 39-46.
6. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993; 90: 10613-10617.
7. Conrad C et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Therapy 1996; 3: 658-668
8. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
9. Knowles MR et al. A controlled study of adenovirus-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl J Med 1995; 333: 823-830.
10. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995; 69: 1473-1479
11. Alexander IE, Russel DW, Miller AD. DNA damaging agents greatly increase the transduction of non-dividing cell by adeno-associated virus vectors J Virol 1994; 69: 8282-8287.
12. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors J Virol 1996, 70 3227-3234.
13. Fisher KJ et al. Transduction with recombinant adeno-associated virus is limited by leading strand synthesis. J Virol 1996, 70 520-532.
14. Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082-14087.
15. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098-8108.
16. Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 1997; 3: 306-312.
17. Peel AL et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Therapy 1997; 4: 16-24.
18. Flannery JG et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 6916-6920.
19. Carter BJ, Flotte TR Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Curr Top Microbiol Immunol 1996; 218: 119-144.
20. Flotte TR et al. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Therapy 1995; 2: 29-37
21. Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
22. Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 5804-5809.
23. Halbert CL et al. Transduction of adeno-associated virus vectors in the rabbit airway: efficiency, persistence and readministration. J Virol 1997; 71: 5932-5941.
24. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.